Two Key Questions About Payer Strategies in 2021

PM360 asked experts in market access and working with payers what innovations to expect ...

Biden Takes Bold Steps to Reverse Years of Healthcare Disparities

We can’t ignore the lessons of the COVID-19 crisis: our healthcare and public health ...

What Trump’s Win Might Mean for Pharma

First, let’s acknowledge the obvious—nobody knows what Trump’s win might mean for the pharma ...

How the Affordable Care Act Changes the Patient Journey (Part Three)

Non-Adherence, Technology and DTC A recent study from Capgemini Consulting found that the pharma ...

How the Affordable Care Act Changes the Patient Journey (Part Two)

Evidence-Based Medicine Along with creating an increase in healthcare demand and the subsequent provider ...

How the Affordable Care Act Changes the Patient Journey (Part One)

Whether you supported it or opposed it, as 2013 unfolds “Obama Care”/ “The Affordable ...

Last Word of the Sunshine Act: The Art of Compliance After the Final Rule

All is finally said and done. Despite some lingering clarifications, the mystery surrounding the ...

Projecting End-to-End Specialty Brand Value

In specialty pharma, brand marketers need to integrate distribution with patient services in order ...